avatar

ASSOCIATE PROF. DR. MARNIZA BINTI SAAD

Faculty of Medicine Dean's Office

Faculty of Medicine

marniza@um.edu.my
Latest Award
Lain-lain
Lain-lain
Year 2019
Latest Evaluation
Advisor : Phase II Study on the Effect of Oral Gamma-Tocotrienol (G-T3) Supplementation on the Overall Survival and Circulating Tumour Cells (CTC) in Subjects with Castration-Resistant Prostate Cancer (CRPC) Advisor : Phase II Study on the Effect of Oral Gamma-Tocotrienol (G-T3) Supplementation on the Overall Survival and Circulating Tumour Cells (CTC) in Subjects with Castration-Resistant Prostate Cancer (CRPC)
Evaluate research protocol

Statistics
Annual Publications by Category
Summary of Budget vs Expenditure per vote for all research grants
Last 5 Projects
Grant Progress Status
Sorry, no accessible project found
This information is generated from Research Grant Management System
Latest Publication
2021

Recent trend of androgen deprivation therapy in newly diagnosed prostate cancer patients: Comparing between high- and middle-income Asian countries

2021

Prostate Cancer Study Group), M-CaP (Malaysia Prostate Cancer Study Group), Rohan Malek, Hideyuki Akaza. Recent trend of androgen deprivation therapy in newly diagnosed prostate cancer patients: Comparing between high-and middle-income Asian countries.

2020

Effectiveness of Decision Aid in Men with Localized Prostate Cancer: a Multicenter Randomized Controlled Trial at Tertiary Referral Hospitals in an Asia Pacific Country,

2020

Clinical outcomes of abiraterone acetate and predictors of its treatment duration in metastatic castration-resistant prostate cancer: Real-world experience in the Southeast Asian cohort

2014

The challenges of drug resistance in renal cell carcinoma.

2018

AR-V7 in Asian patientts with metastatic CRPC : A multinational, multicentre study.

2017

Abiraterone in metastatic castrate resistant prostate cancer: outcome and tolerance in real-world setting.

2017

Efficacy and safety of pazopanib in advanced renal cell carcinoma treated at University Malaya Medical Centre (UMMC).

2016

Real-World experience with abiraterone in metastatic castrate resistant prostate carcinoma in University Malaya Medical Centre.